+987.9%
MRNA vs LDOS
-27.6%
+1,015.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LDOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.7% | +12.4% | +12.7% |
| 7D | +20.6% | -2.8% | +23.5% | +22.0% |
| 30D | +27.1% | +13.6% | +13.6% | +16.8% |
| 3M | +353.4% | +4.2% | +349.2% | +360.3% |
| 6M | +446.3% | -8.2% | +454.5% | +482.1% |
| YTD | +776.2% | -24.1% | +800.3% | +887.9% |
| 1Y | +987.9% | -31.2% | +1,019.1% | +1,273.6% |
| All | +987.9% | -27.6% | +1,015.5% | +1,273.6% |
Cumulative growth
Daily Returns
Daily percentage return beside LDOS.
Daily Out/Under-Performance
Portfolio return minus LDOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LDOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LDOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling